Skip to main content
Equibles

MOLN · Molecular Partners AG · Metrics

Track MOLN — free

Use MOLN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MOLN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.71 -0.10 (-2.60%) At close · Oct 28 Q4 2023 earnings call transcript
Rebalance outlook locked
Market Cap
$145.94M
Shares
38.31M
Volume · Oct 28 1760 Avg daily vol (3M) 1987

MOLN metrics

56 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.71
Market cap
$145.94M

Price action

20 metrics
Price change (1W)
+3.0%
Price change (30D)
-1.3%
Price change (3M)
-0.5%
Price change (6M)
-11.0%
Price change (YTD)
-12.6%
Price change (1Y)
+6.1%
Trailing year
Price change (5Y)
-80.0%
52-week high
$5.13
52-week low
$3.56
Change from 52-week high
-25.7%
Change from 52-week low
+7.0%
Annualized volatility
58.3%
Annualized volatility (3M)
—
Beta
0.5
RSI (14D)
48.7
Price vs SMA 50
-5.7%
Price vs SMA 200
-9.1%
Avg volume (3M)
1,960
Relative volume
1.0
Average dollar volume
$7,867

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
38.31M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
1.9
reciprocal yield 52.7%
FCF yield
-42.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-46.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-25

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$51.70M
Net income (TTM)
−$64.52M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.99

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-87.4%
Return on assets
-67.6%
Debt / equity
—
Current ratio
7.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$58.37M
Quick ratio
7.3
Interest coverage
-118.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$84.05M
Total assets
$93.66M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$58.13M
Capital expenditures (TTM)
$239,498
R&D (TTM)
$46.16M
SG&A (TTM)
—
Stock compensation (TTM)
$4.91M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
5
13F filer change QoQ
+1
Institutional ownership
9.4%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+0.1%
Holder tenure
20.5
Price vs estimated holder cost
-61.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
24 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1745114 CUSIP 60853G106 Visit website Investor relations